Anette Lindqvist
Director of Finance/CFO bei XBRANE BIOPHARMA AB
Vermögen: 5 100 $ am 31.03.2024
Profil
Anette Lindqvist is currently the Chairman of Nanolyze AB and the Chief Financial Officer & Head-Investor Relations at Xbrane Biopharma AB.
Previously, she worked as a Director at Medivir AB from 2022 to 2023, as well as a Director at CombinedX AB and Head-Business Control at Swedish Orphan Biovitrum AB.
She also held a position as Director-Global Clinical Finance at AstraZeneca AB.
Ms. Lindqvist obtained an undergraduate degree from the University of Gothenburg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0,01% | 05.09.2023 | 180 855 ( 0,01% ) | 5 100 $ | 31.03.2024 |
Aktive Positionen von Anette Lindqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| XBRANE BIOPHARMA AB | Director of Finance/CFO | 11.01.2021 |
Nanolyze AB
 Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Chairman | - |
Ehemalige bekannte Positionen von Anette Lindqvist
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVIR AB | Director/Board Member | 20.10.2023 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
| COMBINEDX AB | Director/Board Member | - |
Ausbildung von Anette Lindqvist
| University of Gothenburg | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MEDIVIR AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| XBRANE BIOPHARMA AB | Health Technology |
| COMBINEDX AB | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Nanolyze AB
Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Commercial Services |
